Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Arvinas Inc (NASDAQ: ARVN) was $25.45 for the day, up 2.25% from the previous closing price of $24.89. In other words, the price has increased by $2.25 from its previous closing price. On the day, 0.55 million shares were traded. ARVN stock price reached its highest trading level at $25.865 during the session, while it also had its lowest trading level at $24.87.
Ratios:
Our analysis of ARVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on February 28, 2024, Reiterated its Outperform rating but revised its target price to $80 from $95 previously.
On February 14, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $36 to $55.
On February 01, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $70.Goldman initiated its Buy rating on February 01, 2024, with a $70 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 23 ’24 when Houston John G sold 5,196 shares for $47.05 per share. The transaction valued at 244,472 led to the insider holds 1,036,681 shares of the business.
Cassidy Sean A sold 1,702 shares of ARVN for $80,079 on Feb 23 ’24. The Chief Financial Officer now owns 181,916 shares after completing the transaction at $47.05 per share. On Feb 23 ’24, another insider, Peck Ronald, who serves as the Chief Medical Officer of the company, sold 1,699 shares for $47.05 each. As a result, the insider received 79,938 and left with 67,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 1747094144 and an Enterprise Value of 520493152. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.73 while its Price-to-Book (P/B) ratio in mrq is 2.91. Its current Enterprise Value per Revenue stands at 5.579 whereas that against EBITDA is -1.421.
Stock Price History:
Over the past 52 weeks, ARVN has reached a high of $53.08, while it has fallen to a 52-week low of $13.57. The 50-Day Moving Average of the stock is -4.38%, while the 200-Day Moving Average is calculated to be -24.14%.
Shares Statistics:
ARVN traded an average of 886.86K shares per day over the past three months and 837670 shares per day over the past ten days. A total of 68.00M shares are outstanding, with a floating share count of 59.36M. Insiders hold about 13.54% of the company’s shares, while institutions hold 98.25% stake in the company. Shares short for ARVN as of 1722384000 were 10733135 with a Short Ratio of 12.10, compared to 1719532800 on 9539564. Therefore, it implies a Short% of Shares Outstanding of 10733135 and a Short% of Float of 15.920000000000002.
